Home › Research › Biomarkers
Effect of prior traumatic brain injury on Alzheimer’s disease blood biomarkers in Vietnam Veterans
Lang YR, Vrillon A, Pasternak S, Blazhenets G, Soleimani-Meigooni D, Ravinovici GD, Weiner MW, Hantke N et al.. medRxiv, 2026-01-15
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Results Amyloid-PET positivity prevalence was 30.5%. Results were similar for plasma pTau217 alone and plasma Aβ42/40 ratio. Results were also similar after excluding Veterans with TBI within the past 10 years, or when amyloid-PET positivity was defined using a quantitative threshold rather than consensus visual read. Caution is advised in interpreting AD blood test results in this context. Findings In this cross-sectional study (n=272), plasma pTau217/Aβ42 ratio test accuracy was 90% in Veterans without TBI history, but was significantly lower (63-78% accuracy) in Veterans with TBI history, with lowest accuracy in those with greater TBI severity.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lang, Y. R., Vrillon, A., Pasternak, S., Blazhenets, G., Soleimani-Meigooni, D., Ravinovici, G. D., et al. (2026). Effect of prior traumatic brain injury on Alzheimer’s disease blood biomarkers in Vietnam Veterans. medRxiv. https://doi.org/10.64898/2026.01.13.26344009
Vancouver
Lang YR, Vrillon A, Pasternak S, Blazhenets G, Soleimani-Meigooni D, Ravinovici GD, et al. Effect of prior traumatic brain injury on Alzheimer’s disease blood biomarkers in Vietnam Veterans. medRxiv. 2026. doi:10.64898/2026.01.13.26344009.
BibTeX
@article{lang2026-9b971246,
author = {Lang, Y. R. and Vrillon, A. and Pasternak, S. and Blazhenets, G. and Soleimani-Meigooni, D. and Ravinovici, G. D. and Weiner, M. W. and Hantke, N. and others},
title = {{Effect of prior traumatic brain injury on Alzheimer’s disease blood biomarkers in Vietnam Veterans}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.01.13.26344009},
url = {https://doi.org/10.64898/2026.01.13.26344009}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results Amyloid-PET positivity prevalence was 30.5%.
- Results were similar for plasma pTau217 alone and plasma Aβ42/40 ratio.
- Results were also similar after excluding Veterans with TBI within the past 10 years, or when amyloid-PET positivity was defined using a quantitative threshold rather than consensus visual read.
- Caution is advised in interpreting AD blood test results in this context.
- Findings In this cross-sectional study (n=272), plasma pTau217/Aβ42 ratio test accuracy was 90% in Veterans without TBI history, but was significantly lower (63-78% accuracy) in Veterans with TBI history, with lowest accuracy in those with greater TBI severity.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcohort study
- Participants93
- Effect size30.5%
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 45 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 28 of the 62 points we could judge it on, which is 45 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 1 / 4 | 93 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 28 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 28 of the 62 points we could judge it on is 45 out of 100. |
| Total | 45 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “18f”
318 studies in the library carry the topic tag “18f”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 318 tagged studies.